Immunohematology Blood-Grouping Analyzer Cost Per Test Contract (GSA eBuy)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
GSA-RFQ1787669
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6515
Additional Details
The Defense Health Agency, acting on behalf of the Naval Medical Center Portsmouth (NMCP) in Portsmouth, Virginia, has issued a Combined Synopsis/Solicitation (GSA-RFQ1787669) for a Cost Per Test (CPT) contract to procure two automated immunohematology blood-grouping analyzers. This procurement is conducted exclusively through GSA eBuy, and only quotations submitted directly in response to this RFQ via GSA eBuy will be considered responsive.
Purpose and Scope:
The primary objective of this procurement is to equip the NMCP Transfusion Services Division with two identical, automated immunohematology analyzers, along with all necessary reagents, quality control materials, maintenance services, and consumables. These analyzers are critical for supporting both routine and emergent patient care across the Hampton Roads region and its supported commands. The Transfusion Services Division is responsible for the testing, preparation, and distribution of blood products for surgical, trauma, and hematologic patients, ensuring safe and timely transfusion support through comprehensive immunohematology testing, compatibility verification, and inventory management.
Key Requirements and Deliverables:
The analyzers must be capable of performing essential blood bank testing functions, including ABO/Rh typing, antibody screening, and crossmatching. The systems must be identical to provide redundancy; if a vendor’s solution requires more than one model to fulfill all testing requirements, two of each model must be proposed to maintain system redundancy. The contract also encompasses the provision of all associated reagents, quality control materials, maintenance services, and consumables necessary to ensure uninterrupted analyzer performance, timely software updates, and rapid technical support. These provisions are vital for maintaining compliance with regulatory standards set by the FDA, AABB, and CAP, and for supporting operational readiness and contingency operations.
The analyzers’ integrated software platforms must support automated workflows, data integrity, and traceability, which are essential for clinical care and regulatory compliance. The contract structure is based on a Cost Per Test model, ensuring that all costs associated with testing, including equipment, supplies, and services, are bundled into a single, predictable rate.
Contracting and Administrative Details:
- Contracting Entity: Defense Health Agency (Federal Office)
- Place of Performance: Naval Medical Center Portsmouth, Portsmouth, Virginia, United States
- NAICS Code: 334516 (Analytical Laboratory Instrument Manufacturing)
- Product Service Code: 6515 (Medical and Surgical Instruments, Equipment, and Supplies)
- Set-Aside Status: None (open to all qualified vendors)
- Primary Contact: Matthew Teel ([email protected])
Procurement Process and Special Considerations:
This opportunity is active and subject to several amendments, which have clarified submission instructions, delivery schedules, and pricing sheet requirements. Notably, the pricing sheet (Attachment 2) may be modified by offerors to accurately reflect company-specific products and pricing, provided all instructions are followed. All unit pricing and totals must be rounded to the second decimal place due to system limitations. The procurement is not set aside for any specific business category, and all qualified vendors under the applicable NAICS code are encouraged to participate.
All questions regarding the solicitation must be submitted in writing to the primary contact by 10:00 am ET on Tuesday, December 2, 2025. The final deadline for quotation submission is 10:00 am ET on Wednesday, December 10, 2025.
Summary:
This procurement represents a critical investment in the NMCP’s ability to deliver safe, timely, and compliant transfusion services. Contractors with experience in analytical laboratory instrument manufacturing, particularly those offering automated immunohematology analyzers and comprehensive support packages, are well-positioned to respond. The requirement for system redundancy, regulatory compliance, and integrated support services underscores the importance of reliability and technical excellence in proposed solutions. Interested vendors should carefully review all solicitation documents and amendments, ensure compliance with submission requirements, and direct any questions to the designated point of contact.
For full details and access to all attachments, refer to the official notice on SAM.gov: https://sam.gov/opp/dbfb83154ebe4607bd42b86751d01ef8/view
Documents12